PSYC 1000 Chapter Notes - Chapter 16.3: Monoamine Oxidase, Monoamine Neurotransmitter, Bipolar Disorder

• School: University of Guelph
• Department: Psychology
• Course: PSYC 1000
• Professor: Benjamin Giguere

Document Summary

The use of drugs to attempt to manage or reduce client"s symptoms. A network of tightly packed cells that only allow specific types of substances to move from the bloodstream to the brain in order to protect delicate brain cells against harmful infections and other substances. Designed to cross this barrier and then affect one or more specific neurotransmitters. Medications designed to elevate mood and reduce other symptoms of depression. Target areas of the brain that, when functioning normally are rich in monoamine neurotransmitters serotonin, norepinephrine and dopamine. Work by deactivating monoamine oxidase (mao), an enzyme that breaks down serotonin, dopamine and norepinephrine at the synaptic clefts of the nerve cells. Although effective at relieving the symptoms of depression, they are used less because they have dangerous interactions with fermented foods and other medications. One of the early types of antidepressants. Appear to work by blocking the reuptake of serotonin and norepinephrine.